Objectives: Diaphragm atrophy is associated with delayed weaning from mechanical ventilation and increased mortality in critically ill adults. We sought to test for the presence of diaphragm atrophy in children with acute respiratory failure. Design: Prospective, observational study. Setting: Single-center tertiary noncardiac PICU in a children's hospital. Patients: Invasively ventilated children with acute respiratory failure. Measurements and Main Results: Diaphragm thickness at endexpiration and end-inspiration were serially measured by ultrasound in 56 patients (median age, 17 mo; interquartile range, 5.5-52), first within 36 hours of intubation and last preceding extubation. The median duration of mechanical ventilation was 140 hours (interquartile range, 83-201). At initial measurement, thickness at end-expiration was 2.0 mm (interquartile range, 1.8-2.5) and thickness at end-inspiration was 2.5 mm (interquartile range, 2-2.8). The change in thickness at end-expiration during mechanical ventilation between first and last measurement was -13.8% (interquartile range, -27.4% to 0%), with a -3.4% daily atrophy rate (interquartile range, -5.6 to 0%). Thickening fraction = ([thickness at end-inspiration -thickness at endexpiration]/thickness at end-inspiration) throughout the course of mechanical ventilation was linearly correlated with spontaneous breathing fraction (beta coefficient, 9.4; 95% CI, 4.2-14.7; p = 0.001). For children with a period of spontaneous breathing fraction less than 0.5 during mechanical ventilation, those with exposure to a continuous neuromuscular blockade infusion (n = 15) had a significantly larger decrease in thickness at endexpiration compared with children with low spontaneous breathing fraction who were not exposed to a neuromuscular blockade infusion (n = 18) (-16.4%, [interquartile range, -28.4% to -7.0%] vs -7.3%; [interquartile range, -10.9% to -0%]; p = 0.036). Conclusions: Diaphragm atrophy is present in children on mechanical ventilation for acute respiratory failure. Diaphragm contractility, measured as thickening fraction, is strongly correlated with spontaneous breathing fraction. The combination of exposure to neuromuscular blockade infusion with low overall spontaneous breathing fraction is associated with a greater degree of atrophy. (Pediatr Crit Care Med 2018; 19:406-411) 
A n estimated 30% of children admitted to PICUs in the United States require mechanical ventilation (MV) for a median of 5-6 days (1). Substantial evidence within adult critical care literature supports the existence of ventilator-induced diaphragmatic dysfunction (VIDD), defined as a MV-induced loss of diaphragmatic force-generating capacity characterized by muscle fiber atrophy, myofibril necrosis, and disorganization (2) (3) (4) . Diaphragm atrophy occurs within as few as 18 hours of MV (5) , progresses at a rate between 4% and 7% per day of MV (6) (7) (8) and is associated with extubation failure and increased mortality (9, 10) . The progression of diaphragm atrophy is exacerbated by the length of MV, low spontaneous breathing fraction (SBF), use of neuromuscular blockade (NMB) and exposure to corticosteroids (11) . Although diaphragmatic contraction is integral to the ; Adam S. Himebauch, MD 1, 2 ; Nadir Yehya, MD 1, 2 ; Scott L. Weiss, MD, MSCE, FCCM 1, 2 ; Robert A. Berg, MD, FCCM 1, 2 ; Akira Nishisaki, MD, MSCE 1, 2 generation of inspiratory force (12) in children with immature chest wall musculature, there are limited data on VIDD in pediatric acute respiratory failure (ARF).
Diaphragm contractility can be assessed by measurement of diaphragm thickening during inspiration and expressed as a thickening fraction (TF) (13) (14) (15) . Diaphragm TF correlates strongly with diaphragm strength when assessed against reference measurements of negative intrathoracic pressure in response to phrenic nerve stimulation (16) . Diaphragm atrophy and associated diminished TF (17) have been associated with delayed liberation from MV with the duration of intubation being directly correlated to the level of inspiratory effort (18) . Therefore, diaphragmatic atrophy and resultant dysfunction are likely to be modifiable risk factors in the outcome of pediatric ARF.
Bedside ultrasound (US) is a noninvasive method to interrogate the size and contractility of the diaphragm at its insertion site with the chest wall (the zone of apposition). Contraction in this region drives the inspiratory pressure-volume work relationship and is directly proportional to inspiratory force (19) (20) (21) . To address the lack of pediatric data, we sought to test the hypothesis that diaphragm atrophy occurs in pediatric ARF at a daily rate similar to that seen in adults undergoing MV based on noninvasive US measurements. We also evaluated the correlation between TF and SBF and the association of exposure to continuous NMB infusion and exposure to corticosteroids with diaphragm atrophy during low spontaneous respiratory effort (SBF < 0.5).
MATERIALS AND METHODS

Setting/Population
This study was conducted in an academic, noncardiac, 55-bed PICU in the United States. The study was approved by the institutional review board, and informed consent was obtained from each subject's legal guardian. A convenience sample of subjects younger than 18 years old who required invasive MV for more than 24 hours were enrolled between January 2016 and April 2017. Included subjects were endotracheally intubated and mechanically ventilated with clinician intent to continue MV for more than 24 hours. Subjects with preexisting diagnoses of neuromuscular weakness, diaphragm paresis, chronic respiratory failure with ongoing requirement for invasive MV, or continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) or with likely death within 48 hours were excluded.
Study Design
Enrolled subjects underwent diaphragm measurements by US within 36 hours of initiation of MV. Measurements were repeated 48-72 hours after the initiation of MV, after 1 week of MV and weekly thereafter for the duration of MV. Evaluable subjects were those who had two or more measurements performed during the course of MV. Demographic information, including age, sex, height, weight, primary ICU admission diagnosis, and comorbid conditions, was recorded. Exposure to and duration of continuous NMB infusion during the course of MV (exclusive of intermittent NMB dosing) and use of corticosteroids were recorded. Ventilator logs were interrogated at the time of each US measurement to ascertain the mode of ventilation, ventilator settings, and SBF (the proportion of breaths initiated by the subject during MV) for the 24 hours preceding each US measurement. Extubation success, defined as no requirement for reintubation within the 48 hours following extubation, and requirement for noninvasive ventilation (CPAP or BiPAP) following extubation were recorded.
US Measurements
All US measurements were performed with the SonoSite M-Turbo (FUJIFILM SonoSite, Bothell, Washington) using the L12-4 MHz Linear Array Transducer. Subjects were imaged in a semi-recumbent position with the head of bed at a 30-degree angle. Measurements were made of the right hemidiaphragm since the feasibility and repeatability of right hemidiaphragm measurements are superior to those of the left hemidiaphragm in the adult literature (21) , and no significant difference between diaphragm thickness (Tdi) or TF has been demonstrated between the left and right hemidiaphragms (8, 20, 21) . The transducer was positioned in the coronal plane in the midaxillary line in the zone of apposition between the ninth and 10th intercostal space as first described by Cohn et al (22) and replicated by others (6, 21, 23, 24) . At this position, B-mode US was utilized to measure resting Tdi at end-expiration (Tdiexp) and end-inspiration (Tdi-insp). Tdi-insp was measured during a spontaneous breath for subjects who were capable of spontaneous triggering and during a controlled breath for those who were not spontaneously breathing. Tdi was defined as the outer edge of the peritoneal membrane to the outer edge of the diaphragmatic pleura ( Fig. 1) . In this same position, motion mode ultrasonography was used to measure Tdi-insp and Tdi-exp in order to ascertain diaphragm TF (Fig. 2) . The mean value of three separate measurements was used for analysis. All measurements in the study were performed by a single pediatric intensivist (C.G.) who is credentialed to perform bedside US. A second pediatric intensivist (T.C.) repeated US Figure 1 . B-mode ultrasound image illustrating the measurement of diaphragm thickness at the zone of apposition at end-expiration (EXP) and a shadowing artifact created by an overlying rib.
imaging on four subjects on eight separate occasions coinciding with the timing of the primary ultrasonographer's scans. The interrater reliability correlation coefficient for Tdi measurements was 0.94 (p = 0.0003) for repeated US imaging and measurements by a second provider. Treating clinicians were blinded to the results of the diaphragm measurements and respiratory data; thus, no clinical decisions were made based on the data collected as part of this study.
Statistical Analysis
The sample size calculation was derived from adult literature reporting a baseline diaphragm size of 2.0-3.0 mm (sd, 0.5-1 mm) and daily atrophy rate of 6% during MV (6). We estimated a resting end-expiratory pediatric Tdi of 2.2 mm with sd 0.5 mm and estimated the range of possible percentage change in Tdi to be between -30% and -9%, given the estimated median length of intubation of 5-6 days (1). A total of 52 evaluable subjects would be required to detect the lower percentage estimated change of -9%. Summary statistics were described with mean and sd for parametric variables and mean with interquartile range (IQR) for nonparametric variables. The change of Tdi during MV was calculated as follows: (Tdiexp [last measurement prior to extubation] -Tdi-exp [initial measurement after intubation]) / (Tdi-exp [initial measurement after intubation]). Resting Tdi-exp was used for diaphragm atrophy calculations since inspiratory Tdi is affected by inspiratory effort. The change of Tdi during periods when spontaneous breaths were less than 50% of delivered breaths (SBF < 0.5) was calculated as follows: (Tdi-exp [last measurement during MV with SBF < 0.5] -Tdi-exp [initial measurement after intubation]) / (Tdi-exp [initial measurement after intubation]). Diaphragm TF was calculated at each time point using the following formula: TF = (Tdi-insp -Tdi-exp)/Tdiinsp. Wilcoxon signed rank test was used to assess the subjects' longitudinal Tdi-exp change, and Wilcoxon rank-sum test was used to compare two independent groups. Association between TF and SBF was assessed using linear regression after inspection of data with a two-way scatter plot. Variance was adjusted for clustering within subjects. STATA 14.0 (College Station, TX) was used, and a p value less than 0.05 was considered statistically significant.
RESULTS
A total of 56 subjects were enrolled. Fifty-two subjects had two or more diaphragm measurements allowing for atrophy analyses (four subjects were extubated prior to final diaphragm measurements being performed). Demographics for enrolled subjects are shown in Table 1 . The median length of MV was 140 hours (IQR, 83-201). Extubation failure occurred in 2/56 (3.6%), and 25/56 (44.6%) required noninvasive ventilation (CPAP or BiPAP) during the 24 hours following extubation. The initial diaphragm measurement was done at median 19 hours (IQR, 11.5-28) after intubation, and the final diaphragm measurement was done at median 5 hours (IQR, 2-27) prior to extubation.
Assessment of Diaphragm Atrophy
The initial median Tdi-exp was 2.0 mm (IQR, 1.8-2.5), Tdiinsp 2.2 mm (IQR, 2.0-2.7). The median percentage change in Tdi-exp over the total duration of MV (between initial and final Tdi-exp measurements) was -13.8% (IQR, -27.4 to 0) with a daily rate of atrophy of -3.4% per day of MV (IQR, -5.6 to 0) (Fig. 3) .
Assessment of Diaphragm Thickening Fraction
The median diaphragm TF at the initial measurement was 9.7% (IQR, 6.5-16.4) and within 24 hours prior to extubation was 14.8% (IQR, 10.9-26.8; n = 38). Throughout the course of MV, diaphragm TF was found to be significantly correlated with SBF during the 24 hours preceding each diaphragm measurement (beta coefficient, 9.4; 95% CI, 4.2-14.7; p = 0.001) (Fig. 4) .
Assessment of Diaphragm Atrophy and Exposure to Neuromuscular Blockade
Nineteen subjects received continuous NMB infusion during the study period with median duration of NMB infusion of 68 hours (IQR, 35-98). Subjects exposed to NMB had a longer median length of MV than those not exposed to NMB (158 hr 
Assessment of Diaphragm Atrophy and Exposure to Corticosteroids
Thirty-seven subjects received systemic corticosteroids during MV. There was no significant difference in the daily rate of atrophy among subjects exposed to corticosteroids (-3.8%, [IQR, -6.8 to -0.9]) when compared with unexposed patients (-1.8%, [IQR, -5.1 to 1.8]; p = 0.11). There was a trend toward a greater degree 
Diaphragm Measurements and Correlations During SBF Less Than 0.5
Thirty-three subjects had more than one measurement performed during a period of low spontaneous respiratory effort (SBF < 0.5). The median duration of SBF less than 0.5 among these subjects was 51 hours (IQR, 42-147). The median change in Tdi-exp was -9.0% (IQR, -19.4 to -1.3) with a daily rate of atrophy of -3.9% (IQR, -7.4 to -0.2). For subjects with a period of SBF less than 0.5 during MV, subjects exposed to NMB infusion (n = 15) had a significantly greater degree of diaphragm atrophy than subjects who were not exposed to NMB infusion (n = 18) (median Tdi-exp, -16% [IQR, -28 to -7] vs -7% [IQR, -11 to 0]; p = 0.036) (Fig. 5) . The diaphragm atrophy among subjects who received corticosteroid during SBF less than 
DISCUSSION
In this study, critically ill children with ARF of heterogeneous etiology demonstrated a 3.4% decrease in median Tdi per day of MV. TF was significantly associated with SBF, indicating that the degree of spontaneous respiratory effort during MV is correlated with diaphragm contractility. Children exposed to NMB infusion demonstrated a trend toward higher daily rates of diaphragm atrophy when compared with children not exposed to NMB infusion. A trend toward greater overall diaphragm atrophy in those exposed to corticosteroids was observed when compared with children not exposed to corticosteroids during MV. When comparing subjects with low SBF less than 0.5, subjects with exposure to NMB infusion demonstrated a significantly greater degree of diaphragm atrophy than those with SBF less than 0.5 not exposed to NMB infusion. The substantial daily rate of diaphragm atrophy (3.4%) demonstrated in this study cohort is consistent with adult literature. Zambon et al (8) demonstrated a mean daily change in Tdi of -7.5% ± 12.3 in critically ill adults undergoing controlled MV without pressure support (PS), -5.6% ± 12.9 for subjects in PS ventilation with PS greater than 12 cm H 2 0, and -1.5% ± 10.9 for subjects in PS ventilation with PS 5-12 cm H 2 0. In a multivariable analysis, use of low levels of PS was found to be associated with less diaphragm atrophy, supporting a role for spontaneous ventilation modes that facilitate patient effort. Our study was not powered to detect daily atrophy rates for differing levels of respiratory support or determine whether the degree of PS was predictive of the daily rate of diaphragm atrophy. Nearly all the enrolled subjects were successfully liberated from invasive MV, which limited the ability to assess the clinical significance of diaphragm atrophy with regard to extubation success. Future studies should be performed to investigate the clinical impact of diaphragm atrophy in pediatric ARF. Considering the low rate of extubation failure (4-8%) in pediatric patients on MV for more than 48 hours (25) , this analysis could examine the association of diaphragm atrophy and duration of MV, ICU length of stay, or requirement for noninvasive mechanical ventilatory support following extubation as clinically meaningful outcome metrics.
Our study demonstrated a strong correlation between SBF and diaphragm TF. Although diaphragm atrophy was demonstrated in this study cohort, the median TF at extubation was higher than the initial TF measurement. This could be explained by differences in sedation and NMB use in the initial phases of MV versus the peri-extubation period. The increase in TF prior to extubation could also reflect recovery of diaphragm function during MV weaning prior to clinician determination of extubation readiness. Diminished TF has been demonstrated with increased frequency in adult patients with difficultly weaning from MV (26) . Subjects with diaphragm TF maintained at similar levels to the TF of healthy patients have been demonstrated to have shorter lengths of MV and ICU stay (18) . This suggests that MV strategies that maintain diaphragm contractility may facilitate weaning from MV. TF has also been examined as a potential marker of extubation readiness with TF greater than 36% predictive of a successful spontaneous breathing trial (15) and TF greater than or equal to 30% with successful extubation (10) . These TF cutoff levels are substantially higher than the median TF (13.8%) within 24 hours prior to extubation in this current study, although nearly all (96%) were extubated successfully. This might be explained by nearly half of our patients being extubated to noninvasive MV. Alternatively, this might suggest that the TF threshold predictive of successful extubation may be different in the pediatric population. As diaphragm TF is dependent on patient effort, and within pediatric critical care a large proportion of patients require sedation to facilitate MV, further study is needed to establish normal TF values in children with spontaneous breathing on MV. Whether TF could be utilized as a tool to evaluate extubation readiness in children should be investigated.
During SBF less than 0.5, children exposed to NMB infusion displayed a larger magnitude of atrophy compared with children without exposure to NMB infusion. This suggests that NMB infusion can induce further diaphragm atrophy beyond that created from lack of spontaneous respiratory effort alone. Interestingly, when comparing the total change in Tdi-exp over the entire course of MV, subjects exposed to NMB infusion did not have significantly greater Tdi change than those who were not exposed to NMB infusion. Some of the subjects displayed an initial period of diaphragmatic atrophy followed by a recovery of Tdi during MV before extubation as shown in Figure 3 . This could explain the lack of significant difference between these two groups when the diaphragm atrophy was calculated over the entire duration of MV and suggests a subset of patients in whom muscle atrophy can be reversed.
Our results suggested increased diaphragm atrophy among children who received corticosteroids compared with those who did not, though this did not reach statistical significance. Animal studies have shown mixed results when examining the association of corticosteroid administration with Tdi changes during MV (27) . Adult studies also did not demonstrate significant association between corticosteroid administration and diaphragmatic atrophy during MV (17, 24) . Given that our study was not powered to evaluate the effect of steroid exposure, and the difference between two groups was relatively large (-19.0% in corticosteroid group vs -3.7% in nonexposure group), we believe the effect of corticosteroid exposure on pediatric diaphragm atrophy remains unknown, requiring future study to specifically address this concern.
The current study adds to current literature as the first to examine diaphragm atrophy during MV in the pediatric population and by demonstrating that Tdi and TF measurements are feasible and reproducible in children. The heterogeneity of subjects enrolled in the current study allows these results to be broadly generalizable; however, further study should be conducted to determine the prevalence and severity of diaphragm atrophy in specific disease populations. The current study is limited by a small sample size, which did not provide sufficient power to detect differences in study subgroups. Other limitations include patient heterogeneity, with lack of standardization of MV strategy, NMB, and sedation as well as relatively short median duration of intubation indicating a likely low overall severity of illness in this cohort. Only two subjects failed extubation and many extubated to noninvasive MV; therefore, we were not able to make inferences about the association of diaphragm atrophy and TF with extubation success. The frequency of US measurements was affected by the availability of the ultrasonographer, resulting in limited data points. The ability to perform frequent daily USs on enrolled subjects would have allowed for a richer exploration of diaphragm atrophy rates at varying levels of ventilator support. The study did not account for intermittent doses of NMB administered to patients in the group without exposure to NMB infusion, which could have led to a misclassification bias. No diaphragm measurements were performed following extubation; therefore, the trajectory of change in Tdi following extubation could not be described. In existing adult literature, rapid recovery of Tdi and contractility has been observed (9) . Additional investigation into the recoverability of diaphragm atrophy in the pediatric population should be performed.
CONCLUSION
Progressive diaphragm atrophy occurs in pediatric ARF and is detectable by bedside US. Diaphragm TF was strongly correlated with SBF during MV. Exposure to NMB was associated with a greater rate of diaphragm atrophy when SBF was low. Further study is necessary to explore the clinical implications of diaphragm atrophy in pediatric ARF.
